Forum Home | Log in | Signup | My Page | Rules | FAQ | Boards | Members | Search
« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Nemo - Keytruda 

By: capt_nemo in 6TH POPE | Recommend this post (2)
Sun, 26 Sep 21 3:46 PM | 26 view(s)
Boardmark this board | 6th Edition Pope Board 		Msg. 24357 of 58658
(This msg. is a reply to 24352 by Decomposed)
Jump:
Jump to board:
Jump to msg. #

Thanks DE. Thats sounds promising!!! Bad morning again. I have to get a handle on this chit.....


I can see road blocks with showing this to my doctor. Most hospital are run by the fringe left and Immunity is no longer of their list for consideration!!!!!

Remember. We are terrorist now if we even say, Natural immunity....I am giving it a shot though.




Avatar

Realist - Everybody in America is soft, and hates conflict. The cure for this, both in politics and social life, is the same -- hardihood. Give them raw truth.




» You can also:
- - - - -
The above is a reply to the following message:
Nemo - Keytruda
By: Decomposed in 6TH POPE
Sun, 26 Sep 21 12:10 PM 		Msg. 24352 of 58658

Here's something for you to review or talk to your doctor about. It might give you better results than straight chemo.

http://www.keytruda.com/esophageal-cancer/


RESULTS FOR KEYTRUDA WITH CHEMOTHERAPY
for some patients with advanced esophageal cancer or certain gastroesophageal junction (GEJ) carcinomas

As a first treatment, KEYTRUDA + chemotherapy has been proven to help patients live longer compared to chemotherapy alone

A total of 749 patients with advanced esophageal cancer, or advanced GEJ carcinoma in a particular location, that could not be removed by surgery or treated with chemotherapy and radiation, were enrolled in a clinical trial. The trial compared patients given 200 mg of KEYTRUDA every 3 weeks with chemotherapy (373 patients) to patients given chemotherapy alone (376 patients).

More patients taking KEYTRUDA with chemotherapy lived longer compared to patients taking chemotherapy alone

KEYTRUDA + chemotherapy reduced the risk of disease progression by 35% compared to chemotherapy alone

Half of patients receiving KEYTRUDA with chemotherapy were alive without their cancer spreading, growing, or getting worse at 6.3 months, compared to 5.8 months for patients treated with chemotherapy alone. Cancer did not progress in 20% (76 out of 373) of patients receiving KEYTRUDA with chemotherapy compared to 11% (43 out of 376) of patients receiving chemotherapy alone.

More patients saw tumors shrink

Duration of responses
The median response rate was 8.3 months for patients taking KEYTRUDA (1.2+ to 31.0+ months), compared to 6.0 months for patients taking standard treatment (1.5+ to 25.0+ months).


FDA-Approved Indications
KEYTRUDA is a prescription medicine used to treat a kind of cancer called esophageal or certain gastroesophageal junction (GEJ) carcinomas that cannot be cured by surgery or a combination of chemotherapy and radiation therapy.

KEYTRUDA may be used with platinum- and fluoropyrimidine-based chemotherapy medicines.
KEYTRUDA may be used alone when:
you have received one or more types of treatment, and it did not work or it is no longer working, and
your tumor is a type called “squamous,” and
your tumor tests positive for “PD-L1.”

There's more info on the website.

« 6TH POPE Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next